News
Curated Newsfeed
-
Cleantech startups validate their technologies on land and water
Restor has launched a project with Guatemala government to monitor over half a million hectares and 83,000 sites by 2030 while Neustark launched its first…
startupticker.ch
-
CHF 1.5 billion for Swiss start-ups – high-flyers ensure good numbers
CHF 1.47 billion in venture capital went to Swiss start-ups in the first half of 2025, the third best result ever. A small handful of…
startupticker.ch
-
CHF 79 million to advance Nuclidium’s copper-based radiopharmaceutical platform
NUCLIDIUM AG, a clinical-stage radiopharmaceutical company developing a proprietary copper-based theranostic platform, has closed its Series B financing round led by Kurma Growth Opportunities Fund.…
startupticker.ch
DTN Highlights
-
Read more: From Momentum to Mission: What the Latest VC-Trends Mean for Deep Tech in Switzerland
This mid-year reading of startupticker.ch and SECA’s Swiss VC Report takes the surface rebound—a healthy rise in invested capital—and weighs it against quieter signals: fewer…
-
Read more: Globally Unique Focus on Deep Tech
The first Swiss Deep Tech Report presents data-driven evidence of the advantages that make Switzerland a global deep tech hotspot. It also provides an in-depth…
-
Read more: Deep Tech Nation CEO in Le Temps: “If We Want Economic Giants, We Must Wake Up”
Our CEO, Joanne Sieber, recently sat down with the influential Swiss newspaper Le Temps to discuss a critical challenge for the nation’s future: financing the…
-
Transmutex receives $4 million grant to enable nuclear waste transmutation
Geneva-based startup Transmutex has received more than $4.2 million from the U.S. Department of Energy Advanced Research Projects Agency-Energy as part of the NEWTON Program.…
startupticker.ch
-
Tech Tour Growth Top 50 showcases Swiss deeptech companies
Switzerland is a hub of innovation, home to numerous trailblazing startups, including six that have earned a spot in the Tech Tour Growth Top 50…
startupticker.ch
-
BioVersys to go public at SIX Swiss Exchange
BioVersys develops novel antibacterial products for serious life-threatening infections caused by multidrug-resistant bacteria. The Basel-based company plans to conduct an initial public offering on the…
startupticker.ch
-
Swiss startups strengthen presence in North America
With the establishment of their new offices in the US, Attolight, Blocksport and NewBiologix, aim to increase proximity to customers in the North American market,…
startupticker.ch
-
RhyGaze raises USD 86 million to advance gene therapy for retinal diseases
Based in Basel and Philadelphia, USA, RhyGaze has secured a Series A financing of USD 86 million to enable clinical advancements for its lead candidate,…
startupticker.ch
-
Sygnum achieves unicorn status with USD 58m growth round
Global digital asset banking group Sygnum has raised a total of USD 58 million in its oversubscribed Strategic Growth Round, giving it a post-money valuation…
startupticker.ch
-
Windward Bio launches with $200 million Series A financing round
Founded by serial entrepreneur Luca Santarelli, Windward Bio has just launched with a $200 million capital injection. These funds will accelerate clinical advancements in programs…
startupticker.ch
-
ONWARD Medical wins first commercial customers in the US
With the first commercial sale of the ARC-EX System in the US, ONWARD Medical has reached a key milestone in its journey to provide innovative…
startupticker.ch
-
Numab raises additional CHF50 million
Numab Therapeutics, a clinical stage biotechnology company focusing on multi-specific antibodies in immunology and oncology, closed an oversubscribed CHF 50 million Series C extension, bringing…
startupticker.ch
-
CeQur secures $120 million to scale diabetes management solutions
With more than 6000 patients using the injection-free insulin delivery device, CeQur Simplicity patch, Medtech company CeQur has secured fresh equity funding to further drive…
startupticker.ch
-
Araris enters multi-million contract with Chugai
Araris Biotech AG, a Swiss oncology biotech company developing next-generation antibody drug conjugates (ADCs), has entered a Research Collaboration and Option to License Agreement under…
startupticker.ch
-
Sonar to acquire Tidelift to reduce risk from open source software
Geneva-based Sonar has signed a definitive agreement to acquire Tidelift, a provider of software supply chain security solutions that help organizations manage the risk of…
startupticker.ch
-
Read more: Unlocking Swiss Deep Tech for Institutional Investors
The AWI Deep Tech Fund is bridging the gap between Swiss tech and institutional investors. Discover how it’s unlocking new opportunities.
-
Read more: Swiss AI and the New Autonomous Driving Regulation
As unsurprising as it will sound to people familiar with Switzerland and its priorities, the country spends a lot of time debating, planning, and maintaining…
-
Read more: AWI and DTN Launch AWI DTF Fund Manager Request for Proposals
The Anlagestiftung Winterthur für Personalvorsorge (AWI), in collaboration with Deep Tech Nation Switzerland (DTN), has launched a Request for Proposals (RfP) for the AWI Deep…
-
Read more: Switzerland: The Global Deep Tech Leader
Switzerland was recently named a deep tech beacon by Forbes. Through data backed facts, discover why it’s even more than that; a global deep tech…
-
Read more: Deep Tech Startups Drive Swiss Investment
More venture capital went to Swiss startups from deep tech sectors such as biopharma and hardware & robotics in 2024 than in 2023 – and…
-
Read more: New Information Platform Aims to Boost Funding for Swiss Deep Tech Scaleups
Deep Tech Nation Switzerland Foundation and Startupticker Foundation announce the launch of the Deep Tech Nation Information Platform, a digital portal meant to facilitate investments…
-
Read more: Fajer Mushtaq, Clean Tech Entrepreneur
Fajer Mushtaq, co-founder and CEO of Oxyle, has raised about CHF 9 million in non-dilutive funds in recent years from innovation programmes, the public sector…
-
Read more: Andreas Brenner, Serial Entrepeneur
Andreas Brenner started at the age of 28, when he founded Avrios.com. He spent seven years as CEO responsible for building an SaaS platform that…
-
Read more: Switzerland, Big Pharma’s Shopping Centre
The top pharmaceutical companies are very active in Switzerland, participating in large financing rounds and acquiring companies or drug candidates. In 2024, the global number…
-
Read more: Robots and the Swiss Tradition of Customer Focus
For Swiss robotics startups, customer success and investor success go hand in hand. In addition to outstanding technology, this requires a high degree of customer…